Last reviewed · How we verify

NCT05318235: VIOOL

Virus Interactions in the Respiratory Tract; a Cohort Study With Children

Completed Last updated 9 May 2024
What this trial tests

trial testing No intervention in Respiratory Tract Infections in 229 participants. Completed in 23 April 2024.

Timeline
15 September 2021
Primary endpoint
23 April 2024
23 April 2024

Quick facts

Lead sponsorUMC Utrecht
StatusCompleted
Study typeOBSERVATIONAL
Enrollment229
Start date15 September 2021
Primary completion23 April 2024
Estimated completion23 April 2024
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

UMC Utrecht — full company profile →

Who can join

Adults 6 Weeks to 4, any sex, with Respiratory Tract Infections or Coinfection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rationale: Prevention of virus induced acute respiratory infection (ARI) is a public health priority. As different respiratory virus infections can interact with each other, occurrence of one virus may influence occurrence of other virus infections. Such interactions can have implications for the effects of vaccination on non-target diseases. In this project, we will quantify such interactions between respiratory viruses by longitudinally studying a cohort of young children. Objective: To quantify the strength and direction of interactions between important respiratory virus infections in young children. Study design: This is a prospective observational cohort study. Study population: Children between 6 weeks and 4 years of age residing in the Utrecht area of the Netherlands. Main study parameters/endpoints: Frequency, timing and sequences of occurrence of respiratory virus infections will be studied for each participant using weekly collected nasal specimens during 16 weeks follow-up. Detection will be based on PCR testing for a panel of common respiratory viruses. From these data, estimation of virus interaction parameters will be based on self-controlled-case series analysis. Nature and extend of the burden and risks associated with participation, benefit and group relatedness: This study is observational in nature. There will be no direct benefit to research participants. The study includes biological sampling. The results of the tests done on these samples may not contribute to improving the participant's health. Minimal inconvenience and discomfort to the participant may arise from study visits and biological sampling.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Respiratory Tract Infections

Currently open trials in the same condition.

Other UMC Utrecht trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing